Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00318501
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
EDR | EDROPHONIUM ION | A | 1AX9 | 0.73 |  |
| EDR | EDROPHONIUM ION | A | 2ACK | 0.73 | |
RPF | 1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]- PHENYL}-6-(1,2,,3,4-TETRAHYDRO- QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN- 2-ONE | A,B | 2BKT | 0.72 | |
AL8 | (R)-3,4-DIHYDRO-2-(3-METHOXYPHENYL)- 4-METHYLAMINO-2H-THIENO[3,2-E]- 1,2-THIAZINE-6-SULFONAMIDE-1,1- DIOXIDE | A | 1BNM | 0.73 | |
4BG | N-[4-(benzyloxy)phenyl]glycinamide | A | 3CHO | 0.73 | |
4BS | 4-amino-N-[4-(benzyloxy)phenyl]butanamide | A | 3CHR | 0.7 | |
RJ6 | N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide | A,B,C,D | 3DG8 | 0.77 | |
GNQ | N-[(1R)-1-[(BENZYLSULFONYL)METHYL]- 2-{[(1S)-1-METHYL-2-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}ETHYL]AMINO}- 2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE | A,B | 2HHN | 0.71 | |
| GNQ | N-[(1R)-1-[(BENZYLSULFONYL)METHYL]- 2-{[(1S)-1-METHYL-2-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}ETHYL]AMINO}- 2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE | A,B | 2HH5 | 0.71 | |
HBY | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY- 3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN- 2(1H)-THIONE | A | 2IC3 | 0.8 | |
| HBY | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY- 3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN- 2(1H)-THIONE | A | 1BQM | 0.8 | |
| HBY | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY- 3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN- 2(1H)-THIONE | A | 1BQN | 0.8 | |
| HBY | (S)-4-ISOPROPOXYCARBONYL-6-METHOXY- 3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN- 2(1H)-THIONE | A | 1HQU | 0.8 | |
AL7 | (S)-3,4-DIHYDRO-2-(3-METHOXYPHENYL)- 4-METHYLAMINO-2H-THIENO[3,2-E]- 1,2-THIAZINE-6-SULFONAMIDE-1,1- DIOXIDE | A | 1BNV | 0.73 | |
451 | N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin- 2-yl)acetamide | A | 3FYX | 0.74 | |
TQD | (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}- 1,2,5,6,7,8-hexahydroquinazoline- 2,4-diamine | A | 1S3V | 0.7 | |
| TQD | (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}- 1,2,5,6,7,8-hexahydroquinazoline- 2,4-diamine | A | 1S3U | 0.7 | |
GVB | (3R,4S)-1-(3,4-DIMETHOXYPHENYL)- 3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE | A,B | 2JID | 0.75 | |
INL | 6-[N-(3-METHOXY-PHENYL)-3-(MORPHOLIN- 4-YLMETHYL)-2H-THIENO[3,2-E]-1,2- THIAZINE-1,1,-DIOXIDE]-SULFONAMIDE | A | 1I8Z | 0.72 | |
N4E | N-(4-ethoxyphenyl)acetamide | A,B,C,D | 3EBS | 0.73 | |